Track topics on Twitter Track topics that are important to you
Administering androgen deprivation therapy (ADT) to men with low-risk prostate cancer improves some short-term outcomes. But is it still active surveillance? And do otherwise healthy men need treatment?
Medscape Medical News
Original Article: French Twist: ADT for Prostate Cancer on Active SurveillanceNEXT ARTICLE